Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Random treatment assignment using mathematical equipoise for comparative effectiveness trials.

Selker HP, Ruthazer R, Terrin N, Griffith JL, Concannon T, Kent DM.

Clin Transl Sci. 2011 Feb;4(1):10-6. doi: 10.1111/j.1752-8062.2010.00253.x.

2.

A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.

Kent DM, Ruthazer R, Griffith JL, Beshansky JR, Concannon TW, Aversano T, Grines CL, Zalenski RJ, Selker HP.

Am J Cardiol. 2008 Mar 15;101(6):790-5. doi: 10.1016/j.amjcard.2007.10.050. Epub 2008 Jan 28.

PMID:
18328842
3.

Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.

De Luca G, Biondi-Zoccai G, Marino P.

Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033. Review.

PMID:
19027496
4.

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG.

Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv.

6.

ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon time.

Blankenship JC, Skelding KA, Scott TD, Buckley J, Zimmerman DK, Temple A, Sartorius J, Jimenez E, Berger PB.

Am Heart J. 2009 Sep;158(3):400-7. doi: 10.1016/j.ahj.2009.06.022.

PMID:
19699863
8.

Risk determination after an acute myocardial infarction: review of 3 clinical risk prediction tools.

Scruth EA, Page K, Cheng E, Campbell M, Worrall-Carter L.

Clin Nurse Spec. 2012 Jan-Feb;26(1):35-41. doi: 10.1097/NUR.0b013e31823bfafc. Review.

PMID:
22146272
9.
10.

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.

APEX AMI Investigators, Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D Jr, O'Neill WW, Todaro TG, Vahanian A, Van de Werf F.

JAMA. 2007 Jan 3;297(1):43-51.

PMID:
17200474
11.

Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.

Borgia F, Goodman SG, Halvorsen S, Cantor WJ, Piscione F, Le May MR, Fernández-Avilés F, Sánchez PL, Dimopoulos K, Scheller B, Armstrong PW, Di Mario C.

Eur Heart J. 2010 Sep;31(17):2156-69. doi: 10.1093/eurheartj/ehq204. Epub 2010 Jul 2. Review.

PMID:
20601393
12.

Reanalysis of systematic reviews: the case of invasive strategies for acute coronary syndromes.

Kuukasjärvi P, Nordhausen K, Malmivaara A.

Int J Technol Assess Health Care. 2006 Fall;22(4):484-96.

PMID:
16984682
13.

Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).

Morrison DA, Berman M, El-Amin O, McLaughlin RT, Bates ER.

Minerva Cardioangiol. 2007 Oct;55(5):593-623. Review.

PMID:
17912165
14.

Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.

Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO, Forman SA; Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT).

JAMA. 2002 Apr 17;287(15):1943-51. Erratum in: JAMA 2002 Jun 26;287(24):3212.

PMID:
11960536
15.

Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.

D'Souza SP, Mamas MA, Fraser DG, Fath-Ordoubadi F.

Eur Heart J. 2011 Apr;32(8):972-82. doi: 10.1093/eurheartj/ehq398. Epub 2010 Oct 28. Review.

PMID:
21036776
16.

Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.

Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, Gersh BJ, Wong SC, Witzenbichler B, Guagliumi G, Dudek D, Fahy M, Lansky AJ, Stone GW; HORIZONS-AMI Trial Investigators.

J Am Coll Cardiol. 2011 Aug 9;58(7):704-11. doi: 10.1016/j.jacc.2011.02.071.

17.

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

Kim JS, Kim J, Choi D, Lee CJ, Lee SH, Ko YG, Hong MK, Kim BK, Oh SJ, Jeon DW, Yang JY, Cho JR, Lee NH, Cho YH, Cho DK, Jang Y.

JACC Cardiovasc Interv. 2010 Mar;3(3):332-9. doi: 10.1016/j.jcin.2009.11.021. Erratum in: JACC Cardiovasc Interv. 2012 Feb;5(2):248.

18.

Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument.

Selker HP, Griffith JL, Beshansky JR, Schmid CH, Califf RM, D'Agostino RB, Laks MM, Lee KL, Maynard C, Selvester RH, Wagner GS, Weaver WD.

Ann Intern Med. 1997 Oct 1;127(7):538-56.

PMID:
9313022
19.

Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.

Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group.

Arch Intern Med. 2007 Jul 9;167(13):1353-9.

PMID:
17620527
20.

Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

De Luca G, Marino P.

Am J Emerg Med. 2009 Jul;27(6):683-90. doi: 10.1016/j.ajem.2008.05.021.

PMID:
19751625

Supplemental Content

Support Center